Additional SNPs improve the performance of a polygenic hazard score for prostate cancer
Roshan Karunamuni, Minh-Phuong Huynh-Le, Chun C Fan, Wesley Thompson, Rosalind Eeles, Zsofia Kote-Jarai, Kenneth Muir, Artitaya Lophatananon, UKGPCS collaborators, Johanna Schleutker, Nora Pashayan, Jyotsna Batra, APCB BioResource, Henrik Gronberg, Eleanor Walsh, Emma Turner, Athene Lane, Richard Martin, David Neal, Jenny Donovan, Freddie Hamdy, Borge Nordestgaard, Catherine Tangen, Robert MacInnis, Alicja Wolk, Demetrius Albanes, Christopher Haiman, Ruth Travis, Janet Stanford, Lorelei Mucci, Catharine West, Sune Nielsen, Adam Kibel, Fredrik Wiklund, Olivier Cussenot, Sonja Berndt, Stella Koutros, Karina Sorensen, Cezary Cybulski, Eli Marie Grindedal, Jong Park, Sue Ingles, Christiane Maier, Robert Hamilton, Barry Rossenstein, Ana Vega, The IMPACT Study Steering Committee and Collaborators, Manolis Kogevinas, Kathryn Penney, Manuel Teixeira, Hermann Brenner, Esther John, Radka Kaneva, Christopher Logothetis, Susan Neuhausen, Azad Razack, Lisa Newcomb, Canary PASS Investigators, Marija Gamulin, Nawaid Usmani, Frank Claessens, Manuela Gago-Dominguez, Paul Townsend, Monique Roobol, Wei Zheng, The Profile Study Steering Committee, Ian Mills, Ole Andreassen, Anders Dale, Tyler M Seibert, The PRACTICAL Consortium
medRxiv 2020.09.11.20188383; doi: https://doi.org/10.1101/2020.09.11.20188383
